Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19.
Rauch A, Dupont A, Goutay J, Caplan M, Staessens S, Moussa M, Jeanpierre E, Corseaux D, Lefevre G, Lassalle F, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Van Belle E, Vincent F, Kipnis E, Lenting PJ, Poissy J, Susen S; Lille COVID Research Network (LICORNE); Members of the LICORNE Scientific Committee. Rauch A, et al. Among authors: jeanpierre e. Circulation. 2020 Nov 10;142(19):1881-1884. doi: 10.1161/CIRCULATIONAHA.120.050907. Epub 2020 Sep 24. Circulation. 2020. PMID: 32970476 Free PMC article. No abstract available.
Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins.
Zawadzki C, Susen S, Richard F, Haulon S, Corseaux D, Jeanpierre E, Vincentelli A, Lucas C, Torpier G, Martin A, Van Belle E, Staels B, Jude B. Zawadzki C, et al. Among authors: jeanpierre e. Atherosclerosis. 2007 Dec;195(2):e117-25. doi: 10.1016/j.atherosclerosis.2006.10.012. Epub 2006 Dec 28. Atherosclerosis. 2007. PMID: 17196206
Tissue factor pathway inhibitor-2 gene methylation is associated with low expression in carotid atherosclerotic plaques.
Zawadzki C, Chatelain N, Delestre M, Susen S, Quesnel B, Juthier F, Jeanpierre E, Azzaoui R, Corseaux D, Breyne J, Torpier G, Staels B, Van Belle E, Jude B. Zawadzki C, et al. Among authors: jeanpierre e. Atherosclerosis. 2009 Jun;204(2):e4-14. doi: 10.1016/j.atherosclerosis.2008.10.009. Epub 2008 Oct 19. Atherosclerosis. 2009. PMID: 19081094
Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration.
Breyne J, Juthier F, Corseaux D, Marechaux S, Zawadzki C, Jeanpierre E, Ung A, Ennezat PV, Susen S, Van Belle E, Le Marec H, Vincentelli A, Le Tourneau T, Jude B. Breyne J, et al. Among authors: jeanpierre e. Atherosclerosis. 2010 Dec;213(2):369-76. doi: 10.1016/j.atherosclerosis.2010.07.047. Epub 2010 Aug 4. Atherosclerosis. 2010. PMID: 20732681
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
Van Belle E, Rauch A, Vincentelli A, Jeanpierre E, Legendre P, Juthier F, Hurt C, Banfi C, Rousse N, Godier A, Caron C, Elkalioubie A, Corseaux D, Dupont A, Zawadzki C, Delhaye C, Mouquet F, Schurtz G, Deplanque D, Chinetti G, Staels B, Goudemand J, Jude B, Lenting PJ, Susen S. Van Belle E, et al. Among authors: jeanpierre e. Circ Res. 2015 Mar 27;116(7):1193-201. doi: 10.1161/CIRCRESAHA.116.305046. Epub 2015 Feb 10. Circ Res. 2015. PMID: 25670067
A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
Rauch A, Caron C, Vincent F, Jeanpierre E, Ternisien C, Boisseau P, Zawadzki C, Fressinaud E, Borel-Derlon A, Hermoire S, Paris C, Lavenu-Bombled C, Veyradier A, Ung A, Vincentelli A, van Belle E, Lenting PJ, Goudemand J, Susen S. Rauch A, et al. Among authors: jeanpierre e. Thromb Haemost. 2016 May 2;115(5):950-9. doi: 10.1160/TH15-08-0638. Epub 2016 Jan 21. Thromb Haemost. 2016. PMID: 26791163
Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
Van Belle E, Rauch A, Vincent F, Robin E, Kibler M, Labreuche J, Jeanpierre E, Levade M, Hurt C, Rousse N, Dally JB, Debry N, Dallongeville J, Vincentelli A, Delhaye C, Auffray JL, Juthier F, Schurtz G, Lemesle G, Caspar T, Morel O, Dumonteil N, Duhamel A, Paris C, Dupont-Prado A, Legendre P, Mouquet F, Marchant B, Hermoire S, Corseaux D, Moussa K, Manchuelle A, Bauchart JJ, Loobuyck V, Caron C, Zawadzki C, Leroy F, Bodart JC, Staels B, Goudemand J, Lenting PJ, Susen S. Van Belle E, et al. Among authors: jeanpierre e. N Engl J Med. 2016 Jul 28;375(4):335-44. doi: 10.1056/NEJMoa1505643. N Engl J Med. 2016. PMID: 27464202 Free article.
Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial.
Bouthors AS, Hennart B, Jeanpierre E, Baptiste AS, Saidi I, Simon E, Lannoy D, Duhamel A, Allorge D, Susen S. Bouthors AS, et al. Among authors: jeanpierre e. Trials. 2018 Mar 1;19(1):148. doi: 10.1186/s13063-017-2420-7. Trials. 2018. PMID: 29490682 Free PMC article.
57 results